	Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial. J Clin Oncol Liu T, Luo S, Yuan X, Liu D, Zhou Z, Wang X, Deng Y, Chen J, Liu M, Zhou H, Ren X, Qiu W, Cao Y, Cai S, Dong Y, Zhang Y, Wang W, Liang J, Xu P, Liu H, Zhao K, Fan Y, Dou N, Huang C, Li J. PMID: 41779980 [PubMed - as supplied by publisher]
	Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study). J Clin Oncol Li T, Zhou T, Wang B, Tao Z, Zhao M, Wang L, Jin J, Zhao Y, Gong C, Cao J, Miao H, Peng W, Wang J, Jin M, Hu X, Zhang J. PMID: 41779972 [PubMed - as supplied by publisher]
	A Robust Spectro-Histopathological Diagnostic Method for Improved Gastric Cancer Detection. Anal Chem Il Jang J, Kook MC, Lim SY, Yoon H, Kim HM. PMID: 41779963 [PubMed - as supplied by publisher]
	Prediction of Distant Metastasis in Renal Cell Carcinoma Using Machine Learning Algorithms: A Multicenter Cohort Study. Cancer Control Li Y, Wang X, Wang M, Shou J, Chen C, Wen L. PMID: 41779635 [PubMed - in process]
	Retrospective population-based cohort study on the risk of cardiovascular disease among oesophageal cancer survivors. Br J Surg Kim S, Han KD, Jung J, Song YM, Park JH, Cho JH, Shin DW. PMID: 41779631 [PubMed - in process]
	Briefing on Nitric Oxide a Signal Molecule in Cancer Metastasis and Therapeutic Target. Cell Biochem Funct Kumari S. PMID: 41779613 [PubMed - in process]
	Integrated strategy for breast cancer biomarker analysis using dual ionic liquid aqueous biphasic systems and microfluidic immunoassays. Lab Chip Mendes MSM, Agostinho I, Souza MC, Chu V, Freire MG, E Silva FA, Conde JP. PMID: 41779543 [PubMed - as supplied by publisher]
	Integrated analysis identifies CCNA2 as a candidate diagnostic and prognostic biomarker in oral tongue squamous cell carcinoma. J Appl Oral Sci Gumedag C, Atay S. PMID: 41779475 [PubMed - in process]
	Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers in oral squamous cell carcinoma. An observational case-control study. J Appl Oral Sci Cruz-Romero SD, Baldión AM, Tawil JAH, Escallon A, Rodriguez-Urrego PA, Baldión PA. PMID: 41779471 [PubMed - in process]
	Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study. Cancer Control Do, Y, Erölmez HN, Akda, Y, Yüksel Ya, Sürmeli H, , Sever ÖN, Odaba, Y, Turan N, Gümü. PMID: 41779425 [PubMed - in process]
	Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer: A Randomized Clinical Trial. JAMA Surg Jensen LH, Kjaer M, Diness LV, Hollânder NH, Rahr HB, Pfeffer F, Larsen FO, Lindebjerg J, Rafaelsen SR, Hansen TF, Timm S, Løes IM, Gögenur I, Zitnjak D, Andersen F, Petersen LN, Lindskog EB, Poulsen LØ, Dahl O. PMID: 41779406 [PubMed - as supplied by publisher]
	Preventing Hand-Foot Syndrome in Patients With Cancer: A Systematic Review and Network Meta-Analysis. JAMA Dermatol Baskarane H, Sahni S, Nagpal C, Divakar MK, Pathak N, Kumar S, Bakhshi S, Sagiraju HKR, Singh PP, Agarwal R, Hooda V, Vasudeva P, Batra A. PMID: 41779386 [PubMed - as supplied by publisher]
	Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer. Clin Transl Oncol Zhou B, Wang X, Su L, Liu Y, Zhu M, Guo X, Zhang C. PMID: 41779351 [PubMed - as supplied by publisher]
	Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum. Int J Clin Oncol Kawagoe R, Moriwaki T, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Sugimoto N, Ojima H, Takii Y, Yasui H, Komoda M, Shimada Y, Tsuji A, Yamaguchi T, Sawada R, Shinozaki K, Otsu S, Shigeyasu K, Tsuchihashi K, Tamura T, Shiozawa M, Ueno H, Denda T, Ito T, Takashima A. PMID: 41779341 [PubMed - as supplied by publisher]
	Evaluation of neoadjuvant chemotherapy followed by radical hysterectomy in cervical cancer: a single-center study. Int J Clin Oncol Yamamura A, Ukita M, Takemura H, Ishibashi T, Nakanishi H, Kita M, Sakamoto T, Toda A, Yoshida T, Takahashi S, Kanbayashi S, Tani H, Kosaka K. PMID: 41779340 [PubMed - as supplied by publisher]
	Exploring Patient Perspectives on Upper Tract Urothelial Cancer: A Qualitative Interview Study. Oncol Ther Filipenko D, Acquadro M, Ghatnekar O, Samuelsen CH, Griebsch I. PMID: 41779326 [PubMed - as supplied by publisher]
	Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions. Discov Nano Di Fonte R, Bolognino I, Sommonte F, Serratì S, Fasano R, Arduino I, Iacobazzi RM, Denora N, Perego P, Rossi G, Tosi D, Porcelli L, Azzariti A. PMID: 41779311 [PubMed]
	Authors' Response: Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study. J Gastrointest Cancer Maan MHA, Al-Khazraji A. PMID: 41779300 [PubMed - in process]
	Port Site Excision During Completion Extended Cholecystectomy for Incidental Gallbladder Cancer - A Scoping Review. J Gastrointest Cancer Varshney VK, Singh S, Pandya S, Shelat VG, Chaudhari V, Sikora SS, Kapoor VK. PMID: 41779281 [PubMed - in process]
	Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral. World J Urol Negri F, Basile G, Galdieri A, Longoni M, Raffo M, Pozzi E, Belladelli F, Folcia A, Malvestiti M, Mercinelli C, Necchi A, Colecchia M, Briganti A, Montorsi F, Salonia A, Bandini M. PMID: 41779237 [PubMed - in process]

Articles 1 - 20 / 1913829

Page 1 of 95692



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy